NEGR1 intronic transcript 1 (non-protein coding) (NEGR1-IT1)

NEGR1 intronic transcript 1 (NEGR1-IT1) is a long non-coding RNA (lncRNA) transcribed from the NEGR1 gene locus. Similar functionally annotated lncRNAs at the NEGR1 locus (such as BC048612) have been implicated in the regulation of NEGR1 mRNA expression, influencing NEGR1 protein levels and affecting neuronal maturation and neurite length in neuronal development[2][3]. These lncRNAs do not encode a protein and are not drug targets themselves, nor are they receptors, enzymes, or transporters. Their primary biological significance is thought to be related to regulation of gene expression within the nervous system, potentially influencing central nervous system development and response to injury[2][3]. There is no evidence that NEGR1-IT1 itself serves as a direct therapeutic target, nor that there are approved drugs or established biomarkers for its modulation. Essential clarification: There is little to no literature specifically characterizing "NEGR1 intronic transcript 1 (NEGR1-IT1)" as a therapeutic or druggable target. It is a long non-coding RNA, not a receptor, enzyme, transporter, or member of other canonical therapeutic target classes. Some confusion may arise as NEGR1 (the protein-coding gene and its protein product) is linked to neuronal development, obesity, and some disease phenotypes[1][2][3], but NEGR1-IT1 should not be confused with the NEGR1 protein or other functionally characterized lncRNAs (such as BC048612)[2]. Thus, "NEGR1-IT1" is not a standard therapeutic target, and the query appears likely to involve a non-target molecule or an entity without direct clinical, pharmacological, or biomarker relevance.

Other names

NEGR1-IT1NEGR1 intronic transcript 1NEGR1 intronic transcript 1 (non-protein coding)